声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 来源：市场资讯 国家知识产权局信息显示，中国石油天然气集团有限公司、中国石油集团川庆钻探工程有限公司取得一 项名为"一种交联剂、微交联型聚羧酸分散剂以及相应的制备方法"的专利，授权公告号 CN117304369B，申请日期为2023年11月。 天眼查资料显示，中国石油天然气集团有限公司，成立于1990年，位于北京市，是一家以从事石油和天 然气开采业为主的企业。企业注册资本48690000万人民币。通过天眼查大数据分析，中国石油天然气集 团有限公司共对外投资了110家企业，参与招投标项目5000次，财产线索方面有商标信息1436条，专利 信息5000条，此外企业还拥有行政许可28个。 中国石油集团川庆钻探工程有限公司，成立于2008年，位于成都市，是一家以从事石油和天然气开采业 为主的企业。企业注册资本1160000万人民币。通过天眼查大数据分析，中国石油集团川庆钻探工程有 限公司共对外投资了12家企业，参与招投标项目4274次，专利信息4334条，此外企业还拥有行政许可32 个。 ...

Core Viewpoint - The 2025 Central Display and Audiovisual Industry Ecosystem Summit held in Liuyang highlights the city's emerging industries and its dual focus on traditional and new sectors, aiming for high-quality economic development through a modern industrial system [1][4]. Group 1: Electronic Information Industry - Liuyang signed 115 new projects from January to October this year, with a total investment of 387.34 billion yuan, of which over half (201 billion yuan) is from the electronic information industry [4]. - Leading companies like Lens Technology and Huike Optoelectronics are pivotal in the electronic information sector, driving the industry cluster towards a "trillion-level" scale [4][6]. - Lens Technology has expanded into the automotive sector, supplying major clients like Porsche and Tesla, while also maintaining its leadership in the consumer electronics market [5][6]. - Huike Optoelectronics has invested 320 billion yuan in a new production line for ultra-high-definition displays, significantly enhancing the competitiveness of the local industry [6][7]. Group 2: Biopharmaceutical Industry - Liuyang has become a national-level biopharmaceutical base, with over 280 companies in the sector, including four listed firms and more than 850 approved drug varieties [12][13]. - The recent national drug procurement results show that four local companies secured eight products, reflecting their competitive edge in the market [9][10]. - Companies like Warner Pharmaceutical and Jiutian Pharmaceutical have made significant strides in innovation, with Warner's R&D investment reaching 1.58 billion yuan in 2024, a 53.45% increase year-on-year [13][14]. - The biopharmaceutical sector is transitioning from generic drugs to innovative products, supported by a robust policy framework from the local government [15]. Group 3: Intelligent Equipment Industry - The intelligent equipment sector in Liuyang is also a key industry, with companies focusing on niche markets to achieve competitive advantages [17][18]. - Huayou Vision Technology has become a unique supplier for large automotive components, while other firms like Hunan Fangheng New Materials are leading in specialized materials [16][18]. - The industry has seen significant innovation, with companies like Huaheng Robotics developing advanced automation solutions that enhance production efficiency [19]. - Liuyang's strategy emphasizes the importance of specialization and innovation in driving the growth of its intelligent equipment sector [19].